Apex Therapeutics
Indianapolis, US
Biotech
Founders & leadership
DB
David BroeckerChief Executive Officer; Member of Board of Directors
MR
Mark R. Kelly, PhDChief Scientific Officer; Member of Board of Directors
HR
Homer R. PearceDirector
MR
Martin R. Haslanger, PhDMember of Board of Directors; CEO Emeritus
JR
John R. BarnardMember of Board of Directors; Chairman
RR
Richard R. Messman, MDChief Medical Officer
RR
Roger R. MillerChief Operating Officer
Reported raises · per SEC filings
Form D private placements$150KraisedMar 2019 · 1 investors · Biotechnology
Rule 506(c)$2.8MraisedJul 2018 · 7 investors · Biotechnology
Rule 506(c)$1.3MraisedDec 2016 · 5 investors · Biotechnology
Rule 506(b)$750KraisedFeb 2016 · 3 investors · Biotechnology
Rule 506(b)$275KraisedJun 2015 · 3 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.